Physician profile
Michael Wheelis
NPI 1720052756
$993.69
in general payments reported to CMS, 2019-2025
17 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.63 · 2020: $155 · 2021: $299 · 2022: $92.14 · 2023: $120 · 2024: $75.99 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.65 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $530.30 | 2019-2025 | Ozempic |
| Lilly USA, LLC | $64.25 | 2019-2024 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $51.45 | 2024-2025 | Airsupra, Farxiga |
| Abbvie INC. | $46.60 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.33 | 2025 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $37.05 | 2025 | |
| Exact Sciences Corporation | $35.04 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $30.58 | 2019-2025 | Repatha |
| Kowa Pharmaceuticals America, INC. | $26.95 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.64 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $18.95 | 2025 | Austedo Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.95 | 2025 | Jardiance |
| Paratek Pharmaceuticals, INC. | $15.45 | 2023 | Nuzyra |
| Abbott Laboratories | $15.17 | 2021 | |
| Sanofi Pasteur INC. | $14.83 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.35 | 2019 | |
| Allergan, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wheelis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.